Compugen’s headquarters are Compugen Ltd., 26 Harokmim Street, Bldg. D, Holon, Israel, 5885849. The Company also has offices in South San Francisco, CA.
Compugen was incorporated in Israel in 1993.
Compugen completed its IPO on NASDAQ in August 2000 and listed its shares on the Tel Aviv Stock Exchange in January 2002.
Compugen’s shares are listed on the NASDAQ (Global Market) and the Tel Aviv Stock Exchange under the ticker symbol CGEN.
December 31
Compugen has never paid dividends to its shareholders and does not plan to pay dividends for the foreseeable future.
American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, NY 11219 United States (800) 937-5449 (call center is open Monday through Friday, 8 AM to 8 PM ET) www.astfinancial.com info@amstock.com
Kost Forer Gabbay & Kasierer (a member of Ernst & Young Global), serves as the independent registered public accounting firm of the Company.
These documents can be found in the Investor Relations section of Compugen’s website.
Upcoming events may be viewed on the Events page of the Investor Relations section of Compugen’s website.
Quarterly and annual reports and other investor materials are available in the Investor Relations section of Compugen’s website. Additionally, all SEC filings can also be accessed directly from the SEC website.
On Compugen’s website, www.cgen.com, please go to the Investor Relations section under “Analyst Coverage”.
We believe that Compugen was a PFIC in the taxable years of 2017 and 2019.
U.S. investors who own shares of a PFIC may be subject to certain tax implications. Shareholders are advised to consult their own tax advisors concerning the overall tax consequences of the ownership of ordinary shares arising in their own particular situations under United States federal, state, local or foreign law.
PFIC certificate is available here.
On the Compugen website, under Investor Relations, please complete the “Information Request Form”, or write to ir@cgen.com.